These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3662544)

  • 41. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK; Kushner BH; LaQuaglia M; Kramer K; Gollamudi S; Heller G; Gerald W; Yeh S; Finn R; Larson SM; Wuest D; Byrnes M; Dantis E; Mora J; Cheung IY; Rosenfield N; Abramson S; O'Reilly RJ
    Med Pediatr Oncol; 2001 Jan; 36(1):227-30. PubMed ID: 11464891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroblastoma involvement of the falx cerebri.
    Quackenbush KE; Luna-Fineman S; Magee JF; Gundogan M; Golobi M; Irie T; Fernandez CV
    Pediatr Blood Cancer; 2009 Dec; 53(7):1337-9. PubMed ID: 19821537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unusual Differentiation to Pheochromocytoma-Like Cells in an Adrenal Neuroblastoma After Chemotherapy: A Case Report and Literature Review.
    Tatekawa Y
    Fetal Pediatr Pathol; 2015; 34(5):322-7. PubMed ID: 26207436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies.
    Vietti TJ; Nitschke R; Starling KA; van Eys J
    Cancer Treat Rep; 1979; 63(9-10):1611-4. PubMed ID: 291482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapy of advanced neuroblastoma in children].
    Mutz I
    Wien Med Wochenschr; 1982 Jul; 132(13-14):325-8. PubMed ID: 6182700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epipodophyllotoxin VM-26 in the treatment of childhood neuroblastoma.
    Rivera G; Green A; Hayes A; Avery T; Pratt C
    Cancer Treat Rep; 1977 Oct; 61(7):1243-8. PubMed ID: 589594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemorrhagic shock due to spontaneous rupture of adrenal neuroblastoma in an infant: a rare case and review of the literature.
    Honda S; Miyagi H; Minato M; Kubota KC; Okada T
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):635-7. PubMed ID: 23018564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol.
    Olgun N; Kansoy S; Aksoylar S; Cetingul N; Vergin C; Oniz H; Sarialioglu F; Kantar M; Uysal K; Tuncyurek M; Kargi A; Aktas S; Bayol U; Karaca I; Arikan A; Balik E; Aktug T; Elmas N; Kovanlikaya A; Kinay M; Anacak Y; Degirmenci B; Burak Z
    Pediatr Hematol Oncol; 2003; 20(3):211-8. PubMed ID: 12637217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Profile and outcome of neuroblastoma with convertional chemotherapy in children older than one year: a 15-years experience.
    Bansal D; Marwaha RK; Trehan A; Rao KL; Gupta V
    Indian Pediatr; 2008 Feb; 45(2):135-9. PubMed ID: 18310793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pneumocystis carinii pneumonia: a late presentation following treatment for stage IV neuroblastoma.
    Clarke E; Glaser AW; Picton SV
    Pediatr Hematol Oncol; 2003 Sep; 20(6):467-71. PubMed ID: 14631621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment for stage III-IV neuroblastoma patients: initial response to chemotherapy evaluated by biochemical parameters.
    Imashuku S; Todo S; Nakajima F; Fujita K; Hibi S; Miyake M
    Acta Paediatr Scand; 1991 Oct; 80(10):924-30. PubMed ID: 1755298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient.
    Lones MA; Kirov I; Said JW; Shintaku IP; Neudorf S
    Bone Marrow Transplant; 2000 Nov; 26(9):1021-4. PubMed ID: 11100284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Continuous intravenous infusion therapy of cis-diamminedichloroplatinum (CDDP) in children with neuroblastoma].
    Kobayashi M; Ishikawa Y; Noda M; Hattori T; Okano S; Ito T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3283-6. PubMed ID: 3777965
    [No Abstract]   [Full Text] [Related]  

  • 55. [Phase I study with irinotecan hydrochloride (CPT-11) for advanced neuroblastoma].
    Hirota T; Kawai N; Kitagawa S; Hori T; Konno K; Sawada K; Agata H; Fujimoto T; Tsurusawa M
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2049-54. PubMed ID: 11791383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemophagocytic Lymphohistiocytosis After Initiation of Chemotherapy for Bilateral Adrenal Neuroblastoma.
    Nascimento FA; Nery J; Trennepohl J; Pianovski MA
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):e13-5. PubMed ID: 26583611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma.
    Cheung NV; Heller G
    J Clin Oncol; 1991 Jun; 9(6):1050-8. PubMed ID: 2033419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "Megatherapy" for advanced neuroblastoma--rationale and role.
    Pritchard J
    Eur J Cancer; 1995; 31A(2):134-6. PubMed ID: 7718315
    [No Abstract]   [Full Text] [Related]  

  • 59. Avascular necrosis of bone in neuroblastoma treated with combination chemotherapy.
    Ishii E; Yoshida N; Miyazaki S
    Eur J Pediatr; 1984 Dec; 143(2):152-3. PubMed ID: 6519114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multifocal neuroblastoma with stage IV disease in an 8-year-old boy.
    Kumar J; Kumar A; Seith A; Agarwala S; Bakhshi S
    J Pediatr Hematol Oncol; 2008 May; 30(5):408-9. PubMed ID: 18458582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.